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R&D the biggest business 
casualty of Covid-19?
Summary
While the overall economic impact 
of the Covid-19 pandemic is still 
unfolding, there are strong indications 
that it is causing the largest economic 
downturn since the 2008 financial crisis. 
In 2020, the South African government 
implemented lockdown regulations, 
to safeguard the population, but 
had adverse effects on businesses 
and economic activity at large. This 
brief assesses the effects on firms 
with research and development 
(R&D) activity, and appeals for action 
to protect the national system of 
innovation.
R&D, with its potential to generate 
solutions to health systems challenges 
and growth in new economic sectors, 
may hold the key to attenuating the 
impact of the coronavirus pandemic. 
Perpetually low levels of business R&D 
move South Africa into the group of 
developing countries when ranking 
economies according to knowledge 
intensity. Investment in Science, 
Technology and Innovation (STI) in 
developing countries has become 
increasingly important for these 
countries to meet their goals of inclusive 
economic development. In South Africa, 
the level of investment measured by the 
proportion of GDP accounting for R&D 
is below 1%, and has been at this level 
for at least a decade. This lies well below 
that of other emerging economies such 
as China.
Through an analysis of data from 
the Stats SA rapid response survey1 
conducted during lockdown level 4 
between 1 and 31 May 2020, the brief 
finds that firms with R&D activity in all 
sectors and all size groups experienced 
significant declines in R&D expenditure. 
Of all businesses with R&D activity, an 
average of 40% decreased their R&D 
expenditure. Most disturbingly, R&D 
firms were affected more seriously than 
non-R&D firms by the epidemic, with 
significant numbers of researchers made 
redundant. More than 50% of R&D firms 
laid off staff, with most making up to 
20% of their research staff redundant. 
The consequence is that R&D intensity 
will decrease in the long term, unless 
strong corrective action is taken.
Introduction
In this brief, we present evidence on the 
impact of the Covid-19 crisis on R&D 
activity in South African firms. We use 
firm data collected by Stats SA during 
the course of the pandemic. Due to 
business closures and remote working 
regimes adopted en masse, this data 
was the only large-scale survey of 
economic statistics that was feasible 
during the crisis. The survey included 
questions on R&D and innovation for 
the wave of the survey series conducted 
over the level 4 lockdown. Our interest 
is in the cohort of R&D performing firms. 
The expectation is that, by and large, 
the Covid-19 epidemic and the response 
to it would have a negative effect 
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on economic activity, including R&D 
activity. We conclude the brief with a set 
of policy recommendations, arising from 
the findings presented.
Science and technology is recognised 
as an important component of a 
country’s economic competitiveness. 
The development and exploitation of 
research can demonstrate how public 
sector organisations, such as universities 
and government research organisations, 
working in tandem or side-by-side 
can develop new technologies and 
innovations with a significant impact on 
the economy, and ultimately, transform 
the life of the ordinary citizen. Economic 
development would take place at a 
much slower rate if the public purse 
did not subsidise the very high costs of 
research. The benefits of research would 
not be felt across the broader society 
without capable researchers, engineers, 
and other technically skilled people in 
firms to access the research, and if sales 
and marketing personnel are unable to 
introduce new technologies in the form 
of products to the ordinary citizen.
The bulk of research and development 
activity in any country takes place within 
large firms, many of them multinationals. 
Large firms are better able to absorb the 
high costs of research and can employ 
technically-able personnel at high 
enough levels to successfully use R&D 
as a business strategy. At the same time 
many small firms also rely on R&D as 
a competitive strategy or, indeed, as a 
core activity. Biotech firms, for example, 
typically fall into this category. The high 
cost of research is especially detrimental 
to small firms for which access to 
funding is arguably more difficult.
After World War II, high levels of 
expenditure on R&D have traditionally 
been associated with economically 
developed countries. Increasingly 
countries with emerging economies 
have realised the need for a strong 
science basis and the new millennium 
has seen developing countries such as 
Brazil and China significantly increase 
their levels of R&D spending, with China 
now amongst the highest R&D spenders 
globally, with a historic high of 2,12% of 
GDP in 2017/18.2
In South Africa, the level of spending 
on R&D activity by the science and 
technology complex, consisting of 
public and private R&D performing 
organisations, is one of the highest 
in Africa. However, it is low when 
compared with the leading research 
countries. The proportion of GDP 
devoted to R&D in South Africa was 
0,83% in 2017/18.3 It had been at around 
this level for the preceding decade. 
However, a distinct downward trend 
in the contribution of the business 
sector to R&D expenditure has been 
evident since the start of the new 
millennium.4 This trend has persisted. 
The proportion of business R&D to Gross 
Domestic Expenditure on R&D (GERD) 
declined to less than 50% in 2010/11, 
and has remained below that threshold 
value. Values of GERD below this 
(apparently) critical value are indicative 
of developing economies.
This already low spending is exacerbated 
by external economic shocks such as the 
global Covid-19 pandemic. The Covid-19 
coronavirus, very easily spread during 
human interactions, has potentially fatal 
consequences for a large segment of 
the population once infected. This has 
led governments all over the world to 
implement measures that limit human 
interactions. To curb the pandemic, the 
South African government implemented 
lockdown regulations that limited 
human interactions, inclusive of business 
activities.5 The lockdown regulations 
meant that many businesses had to 
close, limit workforce presence at office 
buildings, or move to remote operations, 
with a detrimental effect on cash flow, 
and, in the case of R&D performers, their 
R&D activity. The extent to which R&D 
performing firms have been affected by 
the pandemic and the response to it is 
the subject of this brief.
While the Covid-19 crisis has led 
to businesses cutting back on R&D 
expenditure, continued investment in 
R&D is essential during the crisis and its 
aftermath for South Africa to achieve the 
goals of the 2030 Agenda for Sustainable 
Development. Furthermore, R&D is 
crucial:6
•  to develop and provide accurate 
data collection and dissemination 
during the Covid-19 crisis period
•  to inform policies to mitigate the 
adverse impact of the pandemic on 
health and the economy
•  to aid in the development of a 
vaccine and other preventive 
measures to combat the spread of 
the disease
•  to provide an in-depth 
understanding of the nature of the 
novel coronavirus and its spread.
Thus R&D remains crucial, not only 
for development, but to find possible 
solutions for the pandemic underway.
Business R&D expenditure is at 
immediate risk as firms decrease or 
halt R&D activities to save costs amid 
dwindling demand and declining 
cash flow.7 By the same token, R&D 
is recognised by many businesses as 
part of the recovery solution. For many 
industries, recovery will not mean 
returning to pre-pandemic business 
as usual. Instead, they must innovate 
to survive and adapt to the ‘new 
normal’, with different ways of working 
and dramatically changed consumer 
demand.
The effect on business
The data collected during the level 
four lockdown by Stats SA in their 
Covid-19 response survey8 showed 
that a significantly large number of 
businesses had cut back on R&D activity. 
About 38% of firms that responded to 
the questionnaire reported a decrease 
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in R&D expenditure. This could be the 
result of decreased cash flow due to low 
demand during the period surveyed. 
On the other hand, the change in 
working environment from the office 
to remote working implied that firms 
had to incur additional expenditure 
including internet costs, subscriptions 
to software such as Zoom and Microsoft 
meetings, and computers and other 
hardware to enable remote working 
environments. Around a third of firms 
reported an increase in the use of 
virtual connections. On the other hand, 
a proportion of firms (12%) took the 
opportunity to go online and offer their 
services via e-commerce platforms, and 
a small section of far-sighted firms (2%) 
invested in equipment to produce new 
products or expand existing product 
lines.
Which R&D firms were affected 
negatively by the crisis?
All firms were affected negatively by 
the crisis, as were the R&D performers. 
Figure 1 shows that across almost all 
industries, more businesses decreased 
R&D expenditure than those that 
increased R&D expenditure in response 
to the changing circumstances. The 
only industry that used the opportunity 
to ramp up R&D was the transport, 
storage and communication sector.9 The 
largest number of firms that cut back 
on R&D activity were in the mining and 
quarrying sector, construction, and the 
electricity, gas and water supply sector, 
where 50% or more of firms decreased 
expenditure on R&D. The community, 
social and personal services sector, 
which houses sections of the health 
sector, saw 25% of firms decrease 
their expenditure on R&D. The much 
beleaguered manufacturing sector was 
also badly affected, with 38% of firms 
curtailing their expenditure on R&D. 
These figures are alarming, as the R&D in 
these industries is crucial for economic 
recovery from the Covid-19 pandemic, 
as well as for finding a vaccine or a 
potential cure.
R&D expenditure by size of enterprises
Further interrogation of the data shows 
that the largest proportion of businesses 
decreasing their R&D expenditure were 
small to medium sized businesses, with 
a turnover of up to R220 million. The 
proportion of businesses that decreased 
their R&D expenditure was an average 
of 40% of all R&D performers. Large R&D 
firms tended to be more persistent in 
maintaining R&D activity. Taking these 
two points together, the proportions are 
probably roughly similar across all size 
classes. In summary, the expectation is 
Figure 1: Proportion of firms that changed their R&D expenditure in response to the Covid-19 
crisis, by industry























































































































Source: Authors’ calculations. Stats SA (2020) Business impact survey of the Covid-19 pandemic in 
South Africa.
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that government’s long-term target of 
GERD/GDP of 1.5% would be adversely 
affected. This is so because recovery in 
R&D activity will be harder to achieve 
than overall economic recovery in the 
long term, due to the specialised nature 
of research.
Staff in R&D firms have been affected 
more seriously by Covid-19
Firms have responded to the crisis 
by laying off staff or decreasing the 
working hours of staff members 
retained. The data in Figure 3 shows 
that in comparison with non-R&D 
performing firms, more R&D firms have 
laid off staff and decreased the hours of 
remaining staff.
Within R&D firms, more than half have 
made researchers redundant. Most of 
these firms made up to 20% of their 
research staff redundant, trying to limit 
the damage by keeping the bulk of their 
R&D teams going. This would leave these 
firms with a reduced ability to compete 
in a post-Covid business environment. 
Over and above the decreases in R&D 
expenditure displayed in Figure 2, Table 1 
shows, disturbingly, that the long-term 
capacity for R&D in the business sector 
has already dropped significantly.
Table 1: Redundancies of researchers in R&D 
firms







It is conceivable that R&D firms may 
cut back further in anticipation of still 
more financial losses. The potential 
to capitalise on R&D requires the 
availability of a skilled workforce capable 
of accessing advanced knowledge 
and utilising it for practical benefit. 
Therefore, the potential for radical 
high-technology innovations would 
be stymied by further cutbacks of this 
nature.
Conclusion
South Africa is not alone in facing 
challenges in stimulating investment 
in STI, as a recent UNCTAD policy brief 
highlighted:
Even though developing 
countries as a group have 
recorded continued growth in R&D 
expenditure over recent years, 
the absolute levels remain small 
and their STI capabilities limited. It 
is therefore crucial for developing 
countries to reinforce their 
commitments to protect investment 
in STI and to design recovery 
packages that leverage technology 
and innovation for sustainable 
development.10
One of the lessons of the 2008 financial 
crisis was that those countries with 
low R&D intensity tended to respond 
to the crisis with austerity measures 
such as streamlining budgets and 
consolidating policies. The outcome 
was to leave already weak STI systems 
in a weaker state than before the crisis, 
which lowered long-term expectations.11 
The response by public sector decision-
makers this time around needs to be far 
more focused and forward looking.
The number of research staff made 
redundant at R&D firms presents the 
national system of innovation with an 
extraordinary challenge. Researchers will 
be lost to the system either by finding 
employment in other fields or by leaving 
the country.
Recommendations
Following the findings of this brief, we 
recommend the following:
1.  The Department of Science and 
Innovation needs to provide 
funding support to R&D firms 
in critical sectors to mitigate the 
negative impact of Covid-19 on cash 
flow, revenue and employment. 
With the pandemic, loans and 
revenues have become difficult to 
acquire, thus, a cushion from DSI 
will support firms’ cash flows. Those 
firms need to be made aware that 
such support will be long-term 
and stable in order to generate 
buy-in and a renewed commitment 
to R&D activities. Even in the 
current economic climate, this is 
not an impractical suggestion. 
Figure 3: Measures taken by R&D firms compared with non-R&D firms to weather the Covid-19 
storm
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Most developed countries and 
many developing countries 
have subsidised businesses to 
protect the income of workers left 
unemployable due to the crisis.
2.  Far more importantly, the DSI needs 
to rapidly develop a programme 
to retain research staff lost to the 
business sector, either by subsidising 
their re-employment in the business 
sector or finding posts in the public 
sector. This could mean increasing 
support for public sector R&D in 
universities and science councils. 
Support schemes should be 
designed for firms with staff that are 
assigned to critical sectors or tasks, 
so that they can effectively return 
to their original employer after 
the crisis.
3.  Lastly, it is also crucial to step up 
investment in new and safe ways 
of working, including through 
the acceleration of digital skills at 
enterprise and worker level. The 
DSI could lead the drive to promote 
remote working within the public 
sector.
References
1.  Stats SA (2020) Business impact 
survey of the Covid-19 pandemic in 
South Africa. Report no. 00-80-01 




2.  OECD (2020) Main science and 
technology indicators: 2020/1. 
Accessed 6 October 2020, http://
oe.cd/msti
3.  CeSTII (2019) South African national 
survey of research and experimental 
development: Statistical report 
2017/18. Pretoria: Department of 
Science and Innovation
4.  Mustapha N, Blankley W, Makelane H 
and Molotja N. (2015) Trends in 
research and development expenditure 
in South Africa (2010–2013): Policy 
implications. Cape Town: HSRC Press, 
Policy Brief
5.  Sekyere E, Bohler-Muller N, 
Hongoro C, and Makoae M (2020) 
The impact of Covid-19 in South 
Africa. Wilson Center, Africa Program 
Occasional Paper
6.  Sirimanne S (2020) Need to protect 
science, technology and innovation 
funding during and after the Covid-19 
crisis. United Nations Conference on 
Trade and Development Policy Brief 
No. 80, May
7.  Royal Academy of Engineering 
(2020) Covid-19 immediate impact on 
R&D-intensive businesses. Accessed 
15 September 2020, raeng.org.uk/
covid19
8.  Stats SA (2020) Business impact 
survey of the Covid-19 pandemic in 
South Africa. Report no. 00-80-01 




9.  It is not known whether this 
formed part of a pre-existing 
trend in the transport storage and 
communication sector, prior to the 
onset of Covid-19.
10.  Sirimanne S (2020) Need to protect 
science, technology and innovation 
funding during and after the Covid-19 
crisis. United Nations Conference on 
Trade and Development Policy Brief 
No. 80, May
11.  Sirimanne S (2020) Need to protect 
science, technology and innovation 
funding during and after the Covid-19 
crisis. United Nations Conference on 
Trade and Development Policy Brief 
No. 80, May
Acknowledgements
The authors wish to thank Dr Glenda 
Kruss and an unknown reviewer for 
insightful comments.
POLICY BRIEF AUTHORS
Atoko Kasongo, PhD; Statistician, Centre 
for Science, Technology and Innovation 
Indicators, HSRC
Nazeem Mustapha, PhD; Chief Research 
Specialist, Centre for Science, Technology and 
Innovation Indicators, HSRC
Enquiries to: 
AKasongo@hsrc.ac.za
View publication stats
